Pamir Ozan — SEC Form 4 filings

SEC reporting owner CIK 1834681. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-08.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-10-23 to 2026-07-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Niagen Bioscience, Inc. (NAGE)Chief Financial Officer63 legs · 9,593 sh · $67,0134

Form 4 filings — Pamir Ozan

FiledFormIssuerReported transactionsSource
2026-07-084Niagen Bioscience, Inc. (NAGE)Grant/award (A): 4,255 @ $2.71EDGAR
2026-02-244Niagen Bioscience, Inc. (NAGE)Grant/award (A): 62,131 (derivative) @ $0EDGAR
2025-11-174Niagen Bioscience, Inc. (NAGE)Purchase (P): 4,464.96 @ $6.81 · Purchase (P): 2,220.44 @ $6.85EDGAR
2025-02-144ChromaDex Corp. (CDXC)Grant/award (A): 17,230 (derivative) @ $0EDGAR
2024-11-254ChromaDex Corp. (CDXC)Purchase (P): 2,907.20 @ $7.36EDGAR
2024-10-234ChromaDex Corp. (CDXC)Grant/award (A): 146,544 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834681 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →